...
首页> 外文期刊>ACS Omega >Using the Variable-Nearest Neighbor Method To Identify P-Glycoprotein Substrates and Inhibitors
【24h】

Using the Variable-Nearest Neighbor Method To Identify P-Glycoprotein Substrates and Inhibitors

机译:使用最近邻法确定P-糖蛋白底物和抑制剂

获取原文

摘要

Permeability glycoprotein (Pgp) is an essential membrane-bound transporter that efficiently extracts compounds from a cell. As such, it is a critical determinant of the pharmacokinetic properties of drugs. Multidrug resistance in cancer is often associated with overexpression of Pgp, which increases the efflux of chemotherapeutic agents from the cell. This, in turn, may prevent an effective treatment by reducing the effective intracellular concentrations of such agents. Consequently, identifying compounds that can either be transported out of the cell by Pgp (substrates) or impair Pgp function (inhibitors) is of great interest. Herein, using publically available data, we developed quantitative structure–activity relationship (QSAR) models of Pgp substrates and inhibitors. These models employed a variable-nearest neighbor (v-NN) method that calculated the structural similarity between molecules and hence possessed an applicability domain, that is, they used all nearest neighbors that met a minimum similarity constraint. The performance characteristics of these v-NN-based models were comparable or at times superior to those of other model constructs. The best v-NN models for identifying either Pgp substrates or inhibitors showed overall accuracies of >80% and κ values of >0.60 when tested on external data sets with candidate Pgp substrates and inhibitors. The v-NN prediction model with a well-defined applicability domain gave accurate and reliable results. The v-NN method is computationally efficient and requires no retraining of the prediction model when new assay information becomes available—an important feature when keeping QSAR models up-to-date and maintaining their performance at high levels.
机译:渗透性糖蛋白(Pgp)是一种必不可少的膜结合转运蛋白,可有效地从细胞中提取化合物。因此,它是药物药代动力学性质的关键决定因素。癌症中的多药耐药性通常与Pgp的过度表达有关,Pgp的过度表达会增加化学治疗剂从细胞中的流出。反过来,这可能会通过降低此类药物的有效细胞内浓度来阻止有效治疗。因此,鉴定可以通过Pgp(底物)运出细胞或削弱Pgp功能(抑制剂)的化合物非常重要。在这里,我们使用公开可用的数据,开发了Pgp底物和抑制剂的定量构效关系(QSAR)模型。这些模型采用可变近邻(v-NN)方法,该方法计算分子之间的结构相似性,因此具有适用性域,也就是说,它们使用了满足最小相似性约束的所有最近邻。这些基于v-NN的模型的性能特征是可比的,有时甚至优于其他模型构造。当使用候选Pgp底物和抑制剂进行外部数据集测试时,用于识别Pgp底物或抑制剂的最佳v-NN模型显示总体准确度> 80%,κ值> 0.60。具有明确定义的适用性域的v-NN预测模型给出了准确而可靠的结果。 v-NN方法的计算效率很高,并且在获得新的测定信息时不需要重新训练预测模型,这是保持QSAR模型最新并保持其高水平性能的重要功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号